Clinical Outcome of Patients with Complete Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancers: The Indian Scenario

Clinical Outcome of Patients with Complete Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancers: The Indian Scenario

Introduction. Neoadjuvant chemoradiotherapy and total mesorectal excision are considered the standard treatment for locally advanced rectal cancer. Various studies have reported pathological downstaging and a complete pathological response rate of 15%–27% following neoadjuvant chemoradiotherapy whi...

Full description

Bibliographic Details
Main Authors:	Sinukumar, Snita, Patil, Prachi, Engineer, Reena, Desouza, Ashwin, Saklani, Avanish
Format:	Online
Language:	English
Published:	Hindawi Publishing Corporation 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295335/

Similar Items

Imaging in rectal cancer with emphasis on local staging with MRI
by: Arya, Supreeta, et al.
Published: (2015)

Desmoplastic small-round-cell rectal tumor
by: Gomes, Rachel M., et al.
Published: (2015)

Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: Chen, Yuan-Gui, et al.
Published: (2016)

Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
by: Zeng, Wei-Gen, et al.
Published: (2015)

Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
by: Huang, Ren-Wen, et al.
Published: (2014)

Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?
by: Sirohi, Bhawna, et al.
Published: (2014)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Li, Yi, et al.
Published: (2016)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
by: Tokuhara, Katsuji, et al.
Published: (2016)

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
by: Travaini, Laura L, et al.
Published: (2016)

Predictive value of APAF-1 and COX-2 expression in pathologic complete response to neoadjuvant chemoradiotherapy for patients with locally advanced rectal adenocarcinoma
by: Peng, Haihua, et al.
Published: (2016)

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Dreussi, Eva, et al.
Published: (2016)

The value of forceps biopsy and core needle biopsy in prediction of pathologic complete remission in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy
by: Tang, Jing-Hua, et al.
Published: (2015)

Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy
by: Wen, Bixiu, et al.
Published: (2015)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
by: Ferrari, Linda, et al.
Published: (2015)

Implantation metastasis from adenocarcinoma of the sigmoid colon into a perianal fistula: a case report
by: Gomes, Rachel M., et al.
Published: (2014)

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari, Chiara, et al.
Published: (2011)

Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
by: Mihmanlı, Mehmet, et al.
Published: (2016)

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
by: McCoy, M., et al.
Published: (2015)

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
by: McCoy, M J, et al.
Published: (2015)

Apparent diffusion coefficient measurement covering complete tumor area better predicts rectal cancer response to neoadjuvant chemoradiotherapy
by: Blažić, Ivana, et al.
Published: (2015)

Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy
by: Xiao, Lin, et al.
Published: (2016)

Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
by: An, Ji Yeong, et al.
Published: (2013)

Diagnostic miss rate for colorectal cancer: an audit
by: Than, Mary, et al.
Published: (2015)

Gastrointestinal cancers in India: Treatment perspective
by: Ghadyalpatil, Nikhil Suresh, et al.
Published: (2016)

Pathological Complete Response of Advanced Rectal Cancer Treated by Preoperative Chemoradiotherapy with Oral Tegafur-Uracil and Leucovorin: A Case Report
by: Wakasugi, Masaki, et al.
Published: (2013)

Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer
by: Peng, Jianhong, et al.
Published: (2016)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
by: Lee, Hong Seok, et al.
Published: (2016)

Signet ring colorectal carcinoma: Do we need to improve the treatment algorithm?
by: Tamhankar, Anup Sunil, et al.
Published: (2016)

Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience
by: Choi, Euncheol, et al.
Published: (2016)

Complete response after chemoradiotherapy for rectal cancer: what is the reasonable approach?
by: Rödel Claus, et al.
Published: (2017-12-01)

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Svoboda, Marek, et al.
Published: (2012)

Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
by: Peng, Hai-Hua, et al.
Published: (2013)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
by: Francesca De Felice, et al.
Published: (2017-05-01)

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
by: Anaïs Chauvin, et al.
Published: (2018-04-01)

The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Liu, Guo-Chen, et al.
Published: (2015)

Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Zhang, Lu-Ning, et al.
Published: (2015)

Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
by: Liu, Guo-Chen, et al.
Published: (2016)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
by: Zhang, Lu-Ning, et al.
Published: (2015)

GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer
by: Lee, Hee Yeon, et al.
Published: (2015)